Tolerability of SGLT2 inhibitors in patients with Fabry disease: An observational study
Cardiac involvement of Fabry disease (FD) includes heart failure (HF) treated according to general guideline recommendations. The retrospective study investigates HF medication in FD focusing on sodium glucose cotransporter 2 (SGLT2) inhibitors. HF medication, laboratory and echocardiographic measur...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2026-06-01
|
| Серія: | American Heart Journal Plus |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2666602226000832 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|